Key result
In patients with chronic renal failure, ultrafiltration reduced elevated IR-ANP levels by 22%, and subsequent saline infusion caused a rapid rise to 150% of baseline.
Why the study?
Does ultrafiltration and saline infusion alter plasma levels of immunoreactive alpha human atrial natriuretic peptide in patients with chronic renal failure?
Population
9 patients with chronic renal failure
Comparison
Removal of 1.3-3.7 litres of fluid by… vs Baseline levels prior to ultrafiltration
Design
Cohort
Authors
Loading...
ANP tracks acute volume shifts in chronic renal failure; supports its physiological role in fluid overload but leaves clinical utility hypothesis-generating.
Does ultrafiltration and saline infusion alter plasma levels of immunoreactive alpha human atrial natriuretic peptide in patients with chronic renal failure?
Atrial natriuretic peptide levels are highly responsive to acute changes in volume status in patients with chronic renal failure, supporting its physiological role in chronic fluid overload.
Walker et al. (1987) studied Chronic renal failure (n=9). Ultrafiltration and saline infusion vs. Baseline was evaluated on Plasma levels of immunoreactive alpha human atrial natriuretic peptide (IR-ANP). In patients with chronic renal failure, ultrafiltration reduced elevated IR-ANP levels by 22%, and subsequent saline infusion caused a rapid rise to 150% of baseline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: